Source: Indian Pharma Post

Strides: Strides receives USFDA approval for anti-inflammatory Celecoxib Capsules

Celecoxib Capsules approval complements Strides' existing products to serve a broader patient base

Read full article »
Annual Revenue
$500M-1.0B
Employees
1.0-5.0K
CEO Avatar

CEO

- -

CEO Approval Rating

- -/100

Read more